Key terms
About PACB
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PACB news
Apr 11
8:06pm ET
Cathie Wood’s ARK Investment bought 349K shares of PacBio today
Apr 02
8:15pm ET
Cathie Wood’s ARK Investment bought 190K shares of PacBio today
Apr 01
8:18pm ET
Cathie Wood’s ARK Investment bought 273K shares of PacBio today
Mar 27
9:00am ET
PacBio’s Revio HiFi sequencing system selected by University of Tartu
Mar 21
6:24pm ET
PacBio price target lowered to $10 from $14 at Canaccord
Feb 22
11:45am ET
Pac Bio call volume above normal and directionally bullish
Feb 20
7:28am ET
PacBio price target lowered to $6.50 from $8 at Piper Sandler
Feb 20
7:27am ET
Pacific Biosciences (PACB) Gets a Buy from Scotiabank
Feb 16
8:07am ET
PacBio price target lowered to $13 from $16 at JPMorgan
Feb 16
7:53am ET
PacBio price target lowered to $15 from $19 at TD Cowen
Feb 16
7:30am ET
Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Integer Holdings (ITGR) and Pacific Biosciences (PACB)
Feb 16
6:59am ET
Pacific Biosciences (PACB) Receives a Hold from Barclays
Feb 16
5:10am ET
PacBio price target lowered to $14 from $15 at Canaccord
Feb 15
10:35pm ET
Buy Rating for Pacific Biosciences: A Strategic Opportunity Amidst Conservative Guidance
Feb 15
4:07pm ET
PacBio reports Q4 EPS (31c), consensus (28c)
Feb 15
11:25am ET
Pac Bio call volume above normal and directionally bullish
Feb 12
2:58pm ET
Canaccord still bullish on 10x Genomics, PacBio despite reducing 2024 estimates
Feb 07
8:09pm ET
Cathie Wood’s ARK Investment bought 908K shares of PacBio today
Feb 07
12:45pm ET
Pac Bio call volume above normal and directionally bullish
Jan 25
5:29am ET
Barclays Remains a Hold on Pacific Biosciences (PACB)
Jan 16
8:05pm ET
Cathie Wood’s ARK Investment bought 340K shares of PacBio today
No recent news articles are available for PACB
No recent press releases are available for PACB
PACB Financials
Key terms
Ad Feedback
PACB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PACB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
